Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2021 Mar 12

PMID 33707946

Citations 16

Authors

Yiran Si

Jian Yue

Zhaoyang Liu

Mo Li

Feng Du

Xue Wang

Zhong Dai

Nanlin Hu

Jie Ju

Songlin Gao

Xiaobing Wang

Peng Yuan

Affiliations

Soon will be listed here.

Abstract

Purpose: Immunologically quiescent of breast cancer cells has been recognized as the key impediment for the breast cancer immunotherapy. In this study, we aimed to investigate the role of nanoparticle-mediated sonodynamic therapy (SDT) in promoting anti-tumor immune of breast cancer cells and its potential immune mechanisms.

Materials And Methods: The phase-transformation nanoparticles (LIP-PFH nanoparticles) were in-house prepared and its physiochemical characters were detected. The CCK-8 assay, apoptosis analysis and Balb/c tumor model establishment were used to explore the anti-tumor effect of LIP-PFH nanoparticles triggered by low-intensity focused ultrasound (LIFU) both in vitro and in vivo. Flow cytometry and immunohistochemistry of CD4T, CD8T, CD8PD-1T in blood, spleen and tumor tissue were performed to represent the change of immune response. Detection of immunogenic cell death (ICD) markers was examined to study the potential mechanisms.

Results: LIP-PFH nanoparticles triggered by LIFU could inhibit the proliferation and promote the apoptosis of 4T1 cells both in vitro and in vivo. CD4T and CD8T cell subsets were significantly increased in blood, spleen and tumor tissue, meanwhile CD8PD-1T cells were reduced, indicating enhancement of anti-tumor immune response of breast cancer cells in the nanoparticle-mediated SDT group. Detection of ICD markers (ATP, high-mobility group box B1, and calreticulin) and flow cytometric analysis of dendritic cell (DC) maturity further showed that the nanoparticle-mediated SDT can promote DC maturation to increase the proportion of cytotoxic T cells by inducing ICD of breast cancer cells.

Conclusion: The therapy of nanoparticles-mediated SDT can effectively enhance anti-tumor immune response of breast cancer.

Citing Articles

Advances in Ultrasound-Targeted Microbubble Destruction (UTMD) for Breast Cancer Therapy.

Wu Y, Liu Y, Wu H, Tong M, Du L, Ren S Int J Nanomedicine. 2025; 20:1425-1442.

PMID: 39925678 PMC: 11804227. DOI: 10.2147/IJN.S504363.

Nanomedicine based on chemotherapy-induced immunogenic death combined with immunotherapy to enhance antitumor immunity.

Chen Y, Mao K, Han D, Ma R, Sun T, Zhang H Front Pharmacol. 2024; 15:1511423.

PMID: 39697556 PMC: 11652165. DOI: 10.3389/fphar.2024.1511423.

Sonodynamic and Acoustically Responsive Nanodrug Delivery System: Cancer Application.

Jeong Y, Park J, Khang D Int J Nanomedicine. 2024; 19:11767-11788.

PMID: 39553460 PMC: 11566213. DOI: 10.2147/IJN.S496028.

Comprehensive review of drug-mediated ICD inhibition of breast cancer: mechanism, status, and prospects.

Wang Y, Yang R, Xie Y, Zhou X, Yang J, Shi Y Clin Exp Med. 2024; 24(1):230.

PMID: 39325106 PMC: 11427550. DOI: 10.1007/s10238-024-01482-1.

Combined Effects of Anti-PD-L1 and Nanosonodynamic Therapy on HCC Immune Activation in Mice: An Investigation.

Wei M, Wang X, Mo Y, Kong C, Zhang M, Qiu G Int J Nanomedicine. 2024; 19:7215-7236.

PMID: 39050875 PMC: 11268760. DOI: 10.2147/IJN.S427144.

References

Xie L, Feng X, Huang M, Zhang K, Liu Q . Sonodynamic Therapy Combined to 2-Deoxyglucose Potentiate Cell Metastasis Inhibition of Breast Cancer. Ultrasound Med Biol. 2019; 45(11):2984-2992. DOI: 10.1016/j.ultrasmedbio.2019.07.008. View

Alexia C, Cren M, Louis-Plence P, Vo D, El Ahmadi Y, Dufourcq-Lopez E . Polyoxidonium Activates Cytotoxic Lymphocyte Responses Through Dendritic Cell Maturation: Clinical Effects in Breast Cancer. Front Immunol. 2019; 10:2693. PMC: 6892947. DOI: 10.3389/fimmu.2019.02693. View

Kitamura T, Qian B, Soong D, Cassetta L, Noy R, Sugano G . CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J Exp Med. 2015; 212(7):1043-59. PMC: 4493415. DOI: 10.1084/jem.20141836. View

Bai X, Ni J, Beretov J, Graham P, Li Y . Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?. Cancer Lett. 2020; 497:100-111. DOI: 10.1016/j.canlet.2020.10.016. View

Salmaninejad A, Zamani M, Pourvahedi M, Golchehre Z, Bereshneh A, Rezaei N . Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers. Immunol Invest. 2016; 45(7):619-40. DOI: 10.1080/08820139.2016.1197241. View

Verma V, Jafarzadeh N, Boi S, Kundu S, Jiang Z, Fan Y . MEK inhibition reprograms CD8 T lymphocytes into memory stem cells with potent antitumor effects. Nat Immunol. 2020; 22(1):53-66. PMC: 10081014. DOI: 10.1038/s41590-020-00818-9. View

Prada F, Sheybani N, Franzini A, Moore D, Cordeiro D, Sheehan J . Fluorescein-mediated sonodynamic therapy in a rat glioma model. J Neurooncol. 2020; 148(3):445-454. DOI: 10.1007/s11060-020-03536-2. View

Lafond M, Yoshizawa S, Umemura S . Sonodynamic Therapy: Advances and Challenges in Clinical Translation. J Ultrasound Med. 2018; 38(3):567-580. DOI: 10.1002/jum.14733. View

Yang Q, Li P, Ran H, Wan J, Chen H, Chen H . Polypyrrole-coated phase-change liquid perfluorocarbon nanoparticles for the visualized photothermal-chemotherapy of breast cancer. Acta Biomater. 2019; 90:337-349. DOI: 10.1016/j.actbio.2019.03.056. View

10.

Wan G, Liu Y, Chen B, Liu Y, Wang Y, Zhang N . Recent advances of sonodynamic therapy in cancer treatment. Cancer Biol Med. 2016; 13(3):325-338. PMC: 5069838. DOI: 10.20892/j.issn.2095-3941.2016.0068. View

11.

Emens L . Breast Cancer Immunotherapy: Facts and Hopes. Clin Cancer Res. 2017; 24(3):511-520. PMC: 5796849. DOI: 10.1158/1078-0432.CCR-16-3001. View

12.

Wang X, Wang N, Yang Y, Wang X, Liang J, Tian X . Polydopamine nanoparticles carrying tumor cell lysate as a potential vaccine for colorectal cancer immunotherapy. Biomater Sci. 2019; 7(7):3062-3075. DOI: 10.1039/c9bm00010k. View

13.

Yang C, Tan Y, Qi H, Zhou J, Long L, Zhan Q . Boosting of the enhanced permeability and retention effect with nanocapsules improves the therapeutic effects of cetuximab. Cancer Biol Med. 2020; 17(2):433-443. PMC: 7309461. DOI: 10.20892/j.issn.2095-3941.2019.0292. View

14.

Schmid P, Adams S, Rugo H, Schneeweiss A, Barrios C, Iwata H . Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. N Engl J Med. 2018; 379(22):2108-2121. DOI: 10.1056/NEJMoa1809615. View

15.

Xu M, Zhou L, Zheng L, Zhou Q, Liu K, Mao Y . Sonodynamic therapy-derived multimodal synergistic cancer therapy. Cancer Lett. 2020; 497:229-242. DOI: 10.1016/j.canlet.2020.10.037. View

16.

Disis M, Stanton S . Immunotherapy in breast cancer: An introduction. Breast. 2017; 37:196-199. DOI: 10.1016/j.breast.2017.01.013. View

17.

Su Y, Fang J, Liao C, Lin C, Li Y, Hu S . Targeted Mesoporous Iron Oxide Nanoparticles-Encapsulated Perfluorohexane and a Hydrophobic Drug for Deep Tumor Penetration and Therapy. Theranostics. 2015; 5(11):1233-48. PMC: 4568451. DOI: 10.7150/thno.12843. View

18.

Ai L, Xu A, Xu J . Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond. Adv Exp Med Biol. 2020; 1248:33-59. DOI: 10.1007/978-981-15-3266-5_3. View

19.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

20.

Ahn S, Hwang J . Global Trends in Immunotherapy Research on Breast Cancer over the Past 10 Years. J Oncol. 2020; 2020:4708394. PMC: 7661143. DOI: 10.1155/2020/4708394. View